HomeKNBIF • OTCMKTS
add
Kane Biotech Inc
Previous close
$0.039
Year range
$0.035 - $0.12
Market cap
9.12M CAD
Avg Volume
29.72K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 125.86K | 117.79% |
Operating expense | 728.20K | -43.36% |
Net income | -1.08M | 31.55% |
Net profit margin | -860.44 | 68.57% |
Earnings per share | — | — |
EBITDA | -782.47K | 36.58% |
Effective tax rate | 120.99% | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 358.81K | -52.11% |
Total assets | 2.49M | -56.10% |
Total liabilities | 4.12M | -70.74% |
Total equity | -1.63M | — |
Shares outstanding | 154.77M | — |
Price to book | -3.91 | — |
Return on assets | -63.71% | — |
Return on capital | -189.83% | — |
Cash Flow
Net change in cash
(CAD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -1.08M | 31.55% |
Cash from operations | -419.88K | 46.84% |
Cash from investing | 31.59K | -96.12% |
Cash from financing | 202.72K | -15.86% |
Net change in cash | -185.56K | -169.88% |
Free cash flow | 258.29K | 138.25% |
About
Founded
2001
Headquarters
Website